DK0461559T3 - Liposomer, der ikke indeholder aktivt stof, til behandling af atherosklerose - Google Patents

Liposomer, der ikke indeholder aktivt stof, til behandling af atherosklerose

Info

Publication number
DK0461559T3
DK0461559T3 DK91109368.0T DK91109368T DK0461559T3 DK 0461559 T3 DK0461559 T3 DK 0461559T3 DK 91109368 T DK91109368 T DK 91109368T DK 0461559 T3 DK0461559 T3 DK 0461559T3
Authority
DK
Denmark
Prior art keywords
atherosclerosis
treatment
active substance
liposomes containing
liposomes
Prior art date
Application number
DK91109368.0T
Other languages
English (en)
Inventor
Juergen Dr Schmitt
Juerg Dr Nehne
Wolfgang Dr Feller
Original Assignee
Inex Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inex Pharmaceuticals Corp filed Critical Inex Pharmaceuticals Corp
Application granted granted Critical
Publication of DK0461559T3 publication Critical patent/DK0461559T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91109368.0T 1990-06-12 1991-06-07 Liposomer, der ikke indeholder aktivt stof, til behandling af atherosklerose DK0461559T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4018767A DE4018767A1 (de) 1990-06-12 1990-06-12 Wirkstofffreie liposomen zur behandlung von atherosklerose

Publications (1)

Publication Number Publication Date
DK0461559T3 true DK0461559T3 (da) 1998-04-27

Family

ID=6408251

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91109368.0T DK0461559T3 (da) 1990-06-12 1991-06-07 Liposomer, der ikke indeholder aktivt stof, til behandling af atherosklerose

Country Status (6)

Country Link
EP (1) EP0461559B1 (da)
AT (1) ATE157876T1 (da)
DE (2) DE4018767A1 (da)
DK (1) DK0461559T3 (da)
ES (1) ES2108698T3 (da)
GR (1) GR3025368T3 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
US6139871A (en) * 1995-07-26 2000-10-31 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US5746223A (en) * 1996-10-11 1998-05-05 Williams; Kevin Jon Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
US6312719B1 (en) 1994-03-04 2001-11-06 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US6773719B2 (en) 1994-03-04 2004-08-10 Esperion Luv Development, Inc. Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
WO1995023592A1 (en) * 1994-03-04 1995-09-08 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
DE69533397D1 (de) * 1994-06-10 2004-09-23 Yissum Res Dev Co Verfahren zur behandlung von hypertonie
AU6915196A (en) * 1995-08-31 1997-03-19 Kurtz, Seymour Therapeutic lipidic vesicles: methods of use and compositions
US5843474A (en) * 1995-10-11 1998-12-01 Reverse Transport Licensing & Consulting, Inc. Method of dialysis treatment, and dialysis apparatus related thereto
FR2764507B1 (fr) * 1997-06-11 2000-10-20 Lipogel Sarl Compositions pulverulentes de liposomes unilamellaires, leur procede de preparation et leurs applications comme complements nutritionnels et comme complements nutritionnels et comme medicaments
RU2128991C1 (ru) * 1998-06-23 1999-04-20 Общество с ограниченной ответственностью "ЭМУ-Темп" Биологически активный эмульсионный препарат
CA2368656A1 (en) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Receptor-ligand pairing for anti-inflammatory response
US20040009216A1 (en) * 2002-04-05 2004-01-15 Rodrigueza Wendi V. Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
US8697120B2 (en) 2006-05-01 2014-04-15 Johns Hopkins University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
WO2008106772A1 (en) * 2007-03-07 2008-09-12 Liponex, Inc. Phospholipid compositions with improved bioavailability and methods for their use
US20200107999A1 (en) * 2017-05-23 2020-04-09 Tci Co., Ltd Emulsified liposome composition and preparation process thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
WO1986001404A1 (en) * 1984-08-28 1986-03-13 Mixson A James Method for using nutrient-containing liposomes in hyperalimentation
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
DE3815473A1 (de) * 1988-05-06 1989-11-16 Karl Heinz Prof Dr Dr Schmidt Wirkstoff-system fuer den lipidaustausch mit zielstrukturen

Also Published As

Publication number Publication date
DE59108850D1 (de) 1997-10-16
EP0461559A3 (en) 1992-07-08
ATE157876T1 (de) 1997-09-15
EP0461559B1 (de) 1997-09-10
EP0461559A2 (de) 1991-12-18
DE4018767A1 (de) 1991-12-19
GR3025368T3 (en) 1998-02-27
ES2108698T3 (es) 1998-01-01

Similar Documents

Publication Publication Date Title
DK0553307T3 (da) Herbicide substituerede arylhalogenalkylpyrazoler
ATE423547T1 (de) N-acyl-phosphatidylethanolamin-vermittelte wirkstoffdarreichung in liposomenform
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
ATE179892T1 (de) Verwendung von lipid-gebundener glykoaminoglykanen zur behandlung der rheumatoider arthritis
BR9714377B1 (pt) compostos derivados de 3-tiocarbamoilpirazol, seus processos de preparaÇço, uso, assim como pesticidas contendo referidos compostos.
NO912758L (no) Anvendelse av det virksomme stoffet flupirtin for bekjempelse av muskelspenninger.
ES2108698T3 (es) Liposomas exentos de sustancias activas, para el tratamiento de aterosclerosis.
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
DE69105635D1 (de) Dibenzoylalkylcyanohydrazine.
TR28150A (tr) Stabilize edilmis agartma bilesimleri.
MX9305187A (es) 2-[(4-heterociclico-fenoximetil)fenoxi]-alcanoatos.
EA199900642A1 (ru) Твердые смеси на базе сульфонилкарбамидов и вспомогательных агентов
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DE59008356D1 (de) Heterocyclische Verbindungen.
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
MX9303084A (es) Agentes fungicidas de 1-aril-3-(3,4-dihidro-4-oxo-3-quinazolinil) urea y composicion que los comprende.
BR8902892A (pt) Processo para a preparacao de hidrazinas substituidas e composicao inseticida
TR199700623T1 (xx) Herbisidler olarak ikame edilmi� 2- fenilpiridinler.
ATE345778T1 (de) (ester)-lysolecithine in liposomen
DE69900297D1 (de) Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung
ATE179882T1 (de) 2-phasen-haarbehandlungsmittel
ATE233745T1 (de) Arzneistoffe
NO912985D0 (no) Forbedret system for transdermal applikasjon av farmasoeytisk aktive forbindelser ved regulert ph.
ATE176477T1 (de) Neue phospholipidderivate
ATE202697T1 (de) Reinigungsmittel, enthaltend farbstabilisator(en) und tensid(e)